NCT00258375 - OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 21, 2005

Primary Completion Date

February 23, 2007

Study Completion Date

September 22, 2008

Conditions

Breast Cancer

Interventions

DRUG

custirsen sodium

DRUG

docetaxel

Trial Locations (5)

British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna

BCCA - Fraser Valley Cancer Centre, Surrey

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver

London Regional Cancer Program at London Health Sciences Centre, London

Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa